About Suraksha Diagnostic Limited
Data last updated: 14 July 2026
Suraksha Diagnostic Limited is a public limited company based in Kolkata, West Bengal, India. It specialises in other hospital and medical care activities, a part of the broader healthcare sector. Incorporated on 15 March 2005, the company has been in operation for over 21 years.
Registered with ROC Kolkata under CIN L85110WB2005PLC102265. Listed.
Capital: an authorised share capital of ₹14 Cr and a paid-up capital of ₹10.42 Cr. It is led by directors including Somnath Chatterjee and Ritu Mittal.
Last AGM: 05 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹310.41 Cr, a growth of 23.14% compared to the previous year. The net worth stands at ₹243.48 Cr (up 15.81% YoY). Total assets are valued at ₹448.12 Cr (up 34.36% YoY).
The company has a workforce of approximately 1,415 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Suraksha Diagnostics. As per MCA filings, the company has open charges of ₹30.95 Cr and satisfied charges of ₹274.15 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surakshanet.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Apps
-
Registered AddressPlot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156
-
IndustryHealthcare, Other Hospital And Medical Care Activities
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has one previous CIN (Corporate Identification Number): U85110WB2005PTC102265. The current CIN is L85110WB2005PLC102265, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110WB2005PLC102265 | Current |
| U85110WB2005PTC102265 | Previous |
Associated Brands with Suraksha Diagnostic Limited
Suraksha Diagnostic Limited operates one associated brand: Suraksha Diagnostics. These brands represent Suraksha Diagnostic Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pathology, molecular diagnostics, and imaging services are provided. | surakshanet.com |
Competitors & Alternatives of Suraksha Diagnostic Limited
Brands and companies operating in the same space as Suraksha Diagnostic Limited include Thyrocare, Krsnaa Diagnostics, Vijaya Diagnostic Centre and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Thyrocare
|
Diagnostic testing centers for pathology and health screenings are operated. | Mumbai, India, India | 1996 |
Krsnaa Diagnostics
|
Chain of radiology & pathology laboratory centers | Pune, India, India | 2011 |
Vijaya Diagnostic Centre
|
Diagnostic services are offered via a chain of centers. | Hyderabad, India, India | 1981 |
Igenetic
|
Provider molecular diagnostic solutions and services | Mumbai, India, India | 2013 |
PH Diagnostic Centre
|
Provider of medical diagnostic services including blood tests, urine tests, and specialized health check-ups | Pune, India, India | 2001 |
Health Ledger
|
Chain of radiology & pathology laboratory centers | Pune, India, India | 2020 |
GD
|
A chain of clinical laboratories is operated for diagnostic services. | Mumbai, India, India | 2007 |
Aarthi Scans
|
Chain of diagnostic centers | Chennai, India, India | 2000 |
Medall
|
Medical diagnostic services are provided through a chain of centres. | Chennai, India, India | 2008 |
Business Activity of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details for Suraksha Diagnostic Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is audited by MSKA & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| MSKA & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is currently managed by 7 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somnath Chatterjee | Managing Director | 15 Mar 2005 | 21 Years 5 Months | Current |
|
Ritu Mittal
Also directs:
Suraksha Speciality Llp, Fetomat Wellness Private Limited, Somatist Therapeutics Private Limited and 5 more
|
Managing Director | 08 Nov 2006 | 19 Years 9 Months | Current |
| Pradip Kumar Dutta | Director | 16 Jul 2024 | 2 Years 1 Months | Current |
|
Satish Kumar Verma
Also directs:
Srd Agencies Llp, Reliance Electronic Industries (India) Llp, Asv Electronics Llp and 5 more
|
Director | 16 Jul 2024 | 2 Years 1 Months | Current |
| Ishani Ray | Director | 16 Jul 2024 | 2 Years 1 Months | Current |
|
Siddhartha Roy
Also directs:
Amgoorie India Ltd
|
Director | 03 Oct 2024 | 1 Years 10 Months | Current |
Financials of Suraksha Diagnostic Limited FY 2026 filings available
Suraksha Diagnostic Limited reported revenue of ₹310.41 Cr (up 23.14% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹310.41 Cr | ₹252.09 Cr |
| Other Income | ₹3.16 Cr | ₹3.85 Cr |
| Total Income | ₹313.58 Cr | ₹255.94 Cr |
| Cost of Materials Consumed | ₹36.48 Cr | ₹29.52 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 |
| Employee Benefit Expense | ₹53.26 Cr | ₹42.89 Cr |
| Finance Costs | ₹12.55 Cr | ₹8.39 Cr |
| Depreciation & Amortisation | ₹41.45 Cr | ₹35.3 Cr |
| Other Expenses | ₹125.29 Cr | ₹98.44 Cr |
| Total Expenses | ₹269.02 Cr | ₹214.53 Cr |
| Profit Before Exceptional Items & Tax | ₹44.56 Cr | ₹41.41 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹44.56 Cr | ₹41.41 Cr |
| Total Tax Expense | ₹13.15 Cr | ₹10.43 Cr |
| Net Profit | ₹31.4 Cr | ₹30.98 Cr |
| attributable to Owners | ₹32.19 Cr | ₹31.82 Cr |
| attributable to NCI | -₹78.46 Lakh | -₹84.62 Lakh |
| Other Comprehensive Income | ₹56.94 Lakh | -₹20.39 Lakh |
| Total Comprehensive Income | ₹31.97 Cr | ₹30.77 Cr |
| EBITDA (computed) | ₹98.56 Cr | ₹85.09 Cr |
| Basic EPS | ₹6.18 | ₹5.97 |
| Diluted EPS | ₹6.18 | ₹5.97 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹448.12 Cr | ₹333.52 Cr |
| Non-current Assets | ₹385.54 Cr | ₹286.37 Cr |
| Current Assets | ₹62.58 Cr | ₹47.15 Cr |
| Property, Plant & Equipment | ₹193.58 Cr | ₹147.14 Cr |
| Inventories | ₹8.14 Cr | ₹8.05 Cr |
| Trade Receivables | ₹22.76 Cr | ₹13.81 Cr |
| Cash & Equivalents | ₹3.21 Cr | ₹2.25 Cr |
| Equity (Net Worth) | ₹243.48 Cr | ₹210.23 Cr |
| Equity Share Capital | ₹10.42 Cr | ₹10.42 Cr |
| Borrowings (Non-current) | ₹17.76 Lakh | ₹2.88 Cr |
| Borrowings (Current) | ₹1.56 Cr | ₹2.95 Cr |
| Total Debt (computed) | ₹1.73 Cr | ₹5.83 Cr |
| Current Liabilities | ₹59.65 Cr | ₹42.72 Cr |
| Total Liabilities | ₹204.64 Cr | ₹123.29 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹81.83 Cr | ₹63.36 Cr |
| Investing Cash Flow | -₹52.17 Cr | -₹39.58 Cr |
| Financing Cash Flow | -₹28.69 Cr | -₹24.05 Cr |
| Capital Expenditure | ₹67.34 Cr | ₹42.02 Cr |
| Free Cash Flow (computed) | ₹14.48 Cr | ₹21.34 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | ₹96.73 Lakh | -₹27.32 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹81.41 Cr | ₹77.69 Cr | ₹78.73 Cr | ₹72.59 Cr | ₹65.09 Cr | ₹59.51 Cr | ₹66.75 Cr |
| Other Income | ₹78.54 Lakh | ₹62.16 Lakh | ₹85.14 Lakh | ₹90.57 Lakh | ₹81.68 Lakh | ₹59.91 Lakh | ₹1.31 Cr |
| Total Income | ₹82.2 Cr | ₹78.31 Cr | ₹79.58 Cr | ₹73.49 Cr | ₹65.91 Cr | ₹60.11 Cr | ₹68.07 Cr |
| Cost of Materials Consumed | ₹10.16 Cr | ₹8.67 Cr | ₹8.9 Cr | ₹8.75 Cr | ₹8.85 Cr | ₹6.1 Cr | ₹7.93 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹13.67 Cr | ₹13.42 Cr | ₹13.39 Cr | ₹12.77 Cr | ₹10.2 Cr | ₹11.29 Cr | ₹11.02 Cr |
| Finance Costs | ₹3.92 Cr | ₹3.16 Cr | ₹2.78 Cr | ₹2.7 Cr | ₹2.06 Cr | ₹1.98 Cr | ₹2.13 Cr |
| Depreciation & Amortisation | ₹11.26 Cr | ₹10.56 Cr | ₹10.14 Cr | ₹9.48 Cr | ₹8.73 Cr | ₹8.83 Cr | ₹8.75 Cr |
| Other Expenses | ₹33.21 Cr | ₹32.44 Cr | ₹32.32 Cr | ₹27.31 Cr | ₹26.86 Cr | ₹23.87 Cr | ₹24.61 Cr |
| Total Expenses | ₹72.22 Cr | ₹68.25 Cr | ₹67.53 Cr | ₹61.02 Cr | ₹56.7 Cr | ₹52.07 Cr | ₹54.43 Cr |
| Profit Before Exceptional Items & Tax | ₹9.98 Cr | ₹10.06 Cr | ₹12.05 Cr | ₹12.47 Cr | ₹9.21 Cr | ₹8.05 Cr | ₹13.63 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹9.98 Cr | ₹10.06 Cr | ₹12.05 Cr | ₹12.47 Cr | ₹9.21 Cr | ₹8.05 Cr | ₹13.63 Cr |
| Total Tax Expense | ₹3.82 Cr | ₹2.82 Cr | ₹3.22 Cr | ₹3.29 Cr | ₹2.04 Cr | ₹2.06 Cr | ₹3.48 Cr |
| Net Profit | ₹6.16 Cr | ₹7.24 Cr | ₹8.83 Cr | ₹9.18 Cr | ₹7.17 Cr | ₹5.98 Cr | ₹10.16 Cr |
| attributable to Owners | ₹6.28 Cr | ₹7.52 Cr | ₹8.99 Cr | ₹9.4 Cr | ₹7.39 Cr | - | ₹10.34 Cr |
| attributable to NCI | -₹12.12 Lakh | -₹28.24 Lakh | -₹15.87 Lakh | -₹22.23 Lakh | -₹21.78 Lakh | - | -₹18.73 Lakh |
| Other Comprehensive Income | ₹28.38 Lakh | ₹9.52 Lakh | -₹42,000 | ₹19.46 Lakh | -₹6.34 Lakh | ₹12.24 Lakh | ₹3.44 Lakh |
| Total Comprehensive Income | ₹6.44 Cr | ₹7.34 Cr | ₹8.82 Cr | ₹9.37 Cr | ₹7.11 Cr | ₹6.11 Cr | ₹10.19 Cr |
| EBITDA (computed) | ₹25.15 Cr | ₹23.78 Cr | ₹24.97 Cr | ₹24.66 Cr | ₹20 Cr | ₹18.86 Cr | ₹24.51 Cr |
| Basic EPS | ₹1.21 | ₹1.44 | ₹1.73 | ₹1.80 | ₹1.42 | ₹1.18 | ₹1.94 |
| Diluted EPS | ₹1.21 | ₹1.44 | ₹1.73 | ₹1.80 | ₹1.42 | ₹1.18 | ₹1.94 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹300.68 Cr | ₹249.1 Cr |
| Other Income | ₹4.35 Cr | ₹4.38 Cr |
| Total Income | ₹305.03 Cr | ₹253.48 Cr |
| Cost of Materials Consumed | ₹36.1 Cr | ₹28.95 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 |
| Employee Benefit Expense | ₹51.67 Cr | ₹41.91 Cr |
| Finance Costs | ₹12.34 Cr | ₹8.39 Cr |
| Depreciation & Amortisation | ₹39.6 Cr | ₹34.73 Cr |
| Other Expenses | ₹118.1 Cr | ₹95.65 Cr |
| Total Expenses | ₹257.82 Cr | ₹209.62 Cr |
| Profit Before Exceptional Items & Tax | ₹47.22 Cr | ₹43.86 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹47.22 Cr | ₹43.86 Cr |
| Total Tax Expense | ₹13.15 Cr | ₹10.42 Cr |
| Net Profit | ₹34.06 Cr | ₹33.44 Cr |
| Other Comprehensive Income | ₹56.94 Lakh | -₹20.39 Lakh |
| Total Comprehensive Income | ₹34.63 Cr | ₹33.24 Cr |
| EBITDA (computed) | ₹99.16 Cr | ₹86.97 Cr |
| Basic EPS | ₹6.54 | ₹6.42 |
| Diluted EPS | ₹6.54 | ₹6.42 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹450.14 Cr | ₹333.1 Cr |
| Non-current Assets | ₹386.67 Cr | ₹288.83 Cr |
| Current Assets | ₹63.47 Cr | ₹44.27 Cr |
| Property, Plant & Equipment | ₹168.53 Cr | ₹139.38 Cr |
| Inventories | ₹8.12 Cr | ₹8.02 Cr |
| Trade Receivables | ₹24.86 Cr | ₹15.06 Cr |
| Cash & Equivalents | ₹2.3 Cr | ₹1.48 Cr |
| Equity (Net Worth) | ₹249.8 Cr | ₹214.31 Cr |
| Equity Share Capital | ₹10.42 Cr | ₹10.42 Cr |
| Borrowings (Non-current) | ₹13.2 Lakh | ₹2.88 Cr |
| Borrowings (Current) | ₹1.53 Cr | ₹2.95 Cr |
| Total Debt (computed) | ₹1.66 Cr | ₹5.83 Cr |
| Current Liabilities | ₹57.36 Cr | ₹38.21 Cr |
| Total Liabilities | ₹200.34 Cr | ₹118.79 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹80.23 Cr | ₹62.8 Cr |
| Investing Cash Flow | -₹51.25 Cr | -₹39.28 Cr |
| Financing Cash Flow | -₹28.15 Cr | ₹24.15 Cr |
| Capital Expenditure | ₹50.12 Cr | ₹35.39 Cr |
| Free Cash Flow (computed) | ₹30.11 Cr | ₹27.41 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | ₹82.91 Lakh | ₹47.66 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹78.56 Cr | ₹75.58 Cr | ₹76.26 Cr | ₹70.28 Cr | ₹64.15 Cr | ₹58.57 Cr | ₹65.95 Cr |
| Other Income | ₹1.3 Cr | ₹98.66 Lakh | ₹96.72 Lakh | ₹1.1 Cr | ₹94.21 Lakh | ₹97.45 Lakh | ₹1.26 Cr |
| Total Income | ₹79.86 Cr | ₹76.57 Cr | ₹77.23 Cr | ₹71.37 Cr | ₹65.09 Cr | ₹59.54 Cr | ₹67.2 Cr |
| Cost of Materials Consumed | ₹10.03 Cr | ₹8.58 Cr | ₹8.8 Cr | ₹8.69 Cr | ₹8.59 Cr | ₹5.99 Cr | ₹7.83 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹13.23 Cr | ₹13.03 Cr | ₹12.99 Cr | ₹12.41 Cr | ₹10 Cr | ₹11.01 Cr | ₹10.71 Cr |
| Finance Costs | ₹3.87 Cr | ₹3.1 Cr | ₹2.72 Cr | ₹2.66 Cr | ₹2.06 Cr | ₹2.03 Cr | ₹2.07 Cr |
| Depreciation & Amortisation | ₹10.69 Cr | ₹10.11 Cr | ₹9.65 Cr | ₹9.15 Cr | ₹8.66 Cr | ₹8.62 Cr | ₹8.58 Cr |
| Other Expenses | ₹31.49 Cr | ₹30.78 Cr | ₹30.5 Cr | ₹25.34 Cr | ₹25.74 Cr | ₹23.47 Cr | ₹23.84 Cr |
| Total Expenses | ₹69.3 Cr | ₹65.6 Cr | ₹64.66 Cr | ₹58.25 Cr | ₹55.05 Cr | ₹51.13 Cr | ₹53.02 Cr |
| Profit Before Exceptional Items & Tax | ₹10.56 Cr | ₹10.97 Cr | ₹12.57 Cr | ₹13.12 Cr | ₹10.04 Cr | ₹8.42 Cr | ₹14.18 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.56 Cr | ₹10.97 Cr | ₹12.57 Cr | ₹13.12 Cr | ₹10.04 Cr | ₹8.42 Cr | ₹14.18 Cr |
| Total Tax Expense | ₹3.85 Cr | ₹2.83 Cr | ₹3.21 Cr | ₹3.27 Cr | ₹2.03 Cr | ₹2.06 Cr | ₹3.43 Cr |
| Net Profit | ₹6.71 Cr | ₹8.14 Cr | ₹9.36 Cr | ₹9.85 Cr | ₹8.01 Cr | ₹6.36 Cr | ₹10.75 Cr |
| Other Comprehensive Income | ₹28.38 Lakh | ₹9.52 Lakh | -₹42,000 | ₹19.46 Lakh | -₹6.34 Lakh | ₹12.24 Lakh | ₹3.44 Lakh |
| Total Comprehensive Income | ₹6.99 Cr | ₹8.24 Cr | ₹9.36 Cr | ₹10.04 Cr | ₹7.94 Cr | ₹6.48 Cr | ₹10.78 Cr |
| EBITDA (computed) | ₹25.11 Cr | ₹24.18 Cr | ₹24.94 Cr | ₹24.93 Cr | ₹20.76 Cr | ₹19.07 Cr | ₹24.83 Cr |
| Basic EPS | ₹1.29 | ₹1.56 | ₹1.80 | ₹1.89 | ₹1.54 | ₹1.22 | ₹2.02 |
| Diluted EPS | ₹1.29 | ₹1.56 | ₹1.80 | ₹1.89 | ₹1.54 | ₹1.22 | ₹2.02 |
Shareholding Pattern of Suraksha Diagnostic Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 49.10%, foreign institutional investors hold 13.46%, domestic institutional investors hold 23.14%, retail and other public shareholders hold 14.31% of Suraksha Diagnostic Limited. The company had 67,107 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 49.10% | 49.00% | 48.98% | 48.88% | 48.78% | 48.78% |
| Public | 50.90% | 51.00% | 51.02% | 51.12% | 51.22% | 51.22% |
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Promoters | 49.10% | 48.78% |
| Public | 50.90% | 51.22% |
| Promoter change (YoY, %pts) | +0.32 | - |
Board & Governance of Suraksha Diagnostic Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Suraksha Diagnostic Limited has 7 directors - 4 independent and 2 executive. The board is chaired by Dr. Somnath Chatterjee.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Dr. Somnath Chatterjee | Executive Director · MD · Chairperson | 2005-03-15 | 1 |
| Ritu Mittal | Executive Director · CEO-MD | 2006-11-08 | 1 |
| Satish Kumar Verma | Non-Executive - Non Independent Director | 2024-07-16 | 3 |
| Pradip Kumar Dutta | Non-Executive - Independent Director | 2024-07-16 | 1 |
| Ishani Ray | Non-Executive - Independent Director | 2024-07-16 | 4 |
| Siddhartha Roy | Non-Executive - Independent Director | 2024-10-03 | 1 |
| Dharam Chand Dharewa | Non-Executive - Independent Director | 2024-10-03 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Ishani Ray (Chairperson), Dharam Chand Dharewa, Ritu Mittal |
| Nomination and remuneration committee | Ishani Ray (Chairperson), Pradip Kumar Dutta, Satish Kumar Verma, Siddhartha Roy |
| Stakeholders Relationship Committee | Siddhartha Roy (Chairperson), Dr. Somnath Chatterjee, Ritu Mittal, Pradip Kumar Dutta |
| Corporate Social Responsibility Committee | Dr. Somnath Chatterjee (Chairperson), Ritu Mittal, Dharam Chand Dharewa |
| Management and Finance Committee | Dr. Somnath Chatterjee (Chairperson), Ritu Mittal, Dharam Chand Dharewa |
Group Structure of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Suraksha Diagnostic Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Suraksha Radiology Private Limited | U86905WB2023PTC265197 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Suraksha Diagnostic Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2026 | Axis Bank Limited | ₹9.82 Cr | Open |
| 30 Jan 2026 | Axis Bank Limited | ₹1.41 Cr | Open |
| 15 Dec 2025 | Axis Bank Limited | ₹8.4 Cr | Open |
| 20 Feb 2025 | Others | ₹60 Lakh | Open |
| 15 May 2023 | Hdfc Bank Limited | ₹50 Lakh | Open |
Total charge records: 50 View all charges
Employees and EPFO Compliance at Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has a workforce of 1,415 employees as of Mar 24, 2024.
Employee and EPFO history for Suraksha Diagnostic Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Suraksha Diagnostic Limited
GST registrations and filing compliance for Suraksha Diagnostic Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Suraksha Diagnostic Limited
Credit ratings, litigation, and regulatory alerts for Suraksha Diagnostic Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Suraksha Diagnostic Limited
MSME payment history for Suraksha Diagnostic Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Suraksha Diagnostic Limited
Corporate group structure for Suraksha Diagnostic Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Suraksha Diagnostic Limited
MCA filings and documents for Suraksha Diagnostic Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Suraksha Diagnostic Limited
Recent News on Suraksha Diagnostic Limited
Frequently Asked Questions about Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is an active public limited company in the healthcare sector based in Kolkata, West Bengal, India. It was incorporated on 15 March 2005 (21+ years old) and is registered under CIN L85110WB2005PLC102265. The company has 1,415 employees.
Suraksha Diagnostic Limited reported revenue of ₹310.41 Cr for FY 2026 (up 23.14% YoY) based on consolidated NSE filings.
The current directors of Suraksha Diagnostic Limited are:
- Somnath Chatterjee - Managing Director
- Ritu Mittal - Managing Director
- Pradip Kumar Dutta - Director
- Satish Kumar Verma - Director
- Ishani Ray - Director
- Siddhartha Roy - Director
- Dharam Chand Dharewa - Director
The primary industry of Suraksha Diagnostic Limited is healthcare. The company specifically operates in other hospital and medical care activities. The company is currently active in this sector.
Yes, Suraksha Diagnostic Limited is a listed company.
Suraksha Diagnostic Limited can be reached at the registered office: Plot No Dg – 121 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156, or through the website surakshanet.com.